Position in CGEM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,061,410
+$2,276,673 QoQ
Shares Held
168,117
+121.7% QoQ
Ownership
0.261%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#47
of 183 holders
Holding Since
Mar 2023
9 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in CGEM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Squarepoint Ops LLC holds $1,238,596,915 across 255 Biotechnology names. CGEM ranks #62 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
198,567 | $123,814,467 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
1,191,732 | $88,760,199 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
233,999 | $70,440,718 | |
| 4 | INSM |
INSMED Inc
|
616,464 | $65,727,391 | |
| 5 | ARGX |
Argenx SE
|
58,400 | $54,181,768 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
422,921 | $46,956,918 | |
| 7 | APGE |
Apogee Therapeutics, Inc.
|
290,713 | $38,586,336 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
154,605 | $37,842,665 |
All Filings in CGEM
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,061,410 | 168,117 | Shares | Defined | 2026-08-14 | |
| 2025-12-31 | $784,737 | 75,820 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $535,585 | 90,318 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $113,010 | 15,008 | Shares | Defined | 2025-08-27 | |
| 2024-12-31 | $232,650 | 19,101 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $515,156 | 30,774 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $186,067 | 10,669 | Shares | Defined | 2024-08-14 | |
| 2023-12-31 | $204,482 | 20,067 | Shares | Defined | 2024-02-14 | |
| 2023-03-31 | $158,585 | 15,502 | Shares | Defined | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||